31644-48-1 Usage
Uses
Used in Pharmaceutical Industry:
2-amino-N-pyridin-2-ylethanesulfonamide is used as an active pharmaceutical ingredient for its potential anti-cancer and anti-inflammatory properties. Its unique structure allows it to target specific biological pathways, making it a promising candidate for the development of new drugs to treat various diseases.
Used in Agrochemical Industry:
2-amino-N-pyridin-2-ylethanesulfonamide is used as a building block in the synthesis of agrochemicals. Its chemical properties make it suitable for the development of new pesticides and herbicides, contributing to more effective and targeted agricultural solutions.
Used in Chemical Synthesis:
2-amino-N-pyridin-2-ylethanesulfonamide is used as a versatile building block in the synthesis of various chemical compounds. Its unique structure and functional groups make it a valuable component in the development of new materials and products across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 31644-48-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,4 and 4 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 31644-48:
(7*3)+(6*1)+(5*6)+(4*4)+(3*4)+(2*4)+(1*8)=101
101 % 10 = 1
So 31644-48-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H11N3O2S/c8-4-6-13(11,12)10-7-3-1-2-5-9-7/h1-3,5H,4,6,8H2,(H,9,10)
31644-48-1Relevant academic research and scientific papers
Amido pyrimidine compound
-
Paragraph 0327-0329, (2020/06/20)
The invention provides an amido pyrimidine compound with a novel structure as shown in a formula (I) and a preparation method and application of the amido pyrimidine compound. The amido pyrimidine compound is a compound shown as the formula (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer or tautomer thereof and the like. The amido pyrimidine compound provided bythe invention has a relatively good proliferation inhibition effect on various cancer cells; according to the present invention, the compound has characteristics of low tumor cell inhibition concentration, significantly-improved compound activity, good tumor cell selectivity and good solubility, and is expected to be a specific drug for treatment of malignant tumor cell abnormal proliferation diseases caused by EGFR mutation.
